Have your own idea? Try our Stock Screener
Indian (NIFTY) Healthcare Sector Analysis
UpdatedApr 12, 2026
DataAggregated Company Financials
Companies324
- 7D3.4%
- 3M-2.0%
- 1Y4.5%
- YTD-2.2%
In the last week, the Healthcare industry is up 3.4%, with Divi's Laboratories up 4.4%. This takes the industry's 12 month performance to a gain of 4.5%. As for the next few years, earnings are expected to grow by 21% per annum.
Sector Valuation and Performance
Has the Indian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 13 Apr 2026 | ₹29.8t | ₹5.9t | ₹780.6b | 29.3x | 38.1x | 5x |
| Wed, 11 Mar 2026 | ₹30.4t | ₹5.9t | ₹780.6b | 28.3x | 39x | 5.1x |
| Fri, 06 Feb 2026 | ₹29.4t | ₹5.8t | ₹770.4b | 29.6x | 38.1x | 5.1x |
| Sun, 04 Jan 2026 | ₹30.5t | ₹5.7t | ₹772.9b | 33.8x | 39.5x | 5.3x |
| Tue, 02 Dec 2025 | ₹30.7t | ₹5.7t | ₹767.7b | 33.1x | 40x | 5.4x |
| Thu, 30 Oct 2025 | ₹30.9t | ₹5.5t | ₹737.0b | 35.6x | 41.9x | 5.6x |
| Sat, 27 Sep 2025 | ₹29.6t | ₹5.5t | ₹730.2b | 35.9x | 40.6x | 5.4x |
| Mon, 25 Aug 2025 | ₹30.7t | ₹5.5t | ₹730.0b | 36.3x | 42.1x | 5.6x |
| Wed, 23 Jul 2025 | ₹30.8t | ₹5.3t | ₹732.0b | 36.9x | 42.1x | 5.8x |
| Fri, 20 Jun 2025 | ₹29.0t | ₹5.3t | ₹728.3b | 35.5x | 39.8x | 5.4x |
| Sun, 18 May 2025 | ₹28.6t | ₹5.3t | ₹707.2b | 34.7x | 40.5x | 5.4x |
| Tue, 15 Apr 2025 | ₹28.1t | ₹5.2t | ₹680.2b | 32.8x | 41.3x | 5.4x |
| Thu, 13 Mar 2025 | ₹26.7t | ₹5.2t | ₹680.1b | 30.4x | 39.3x | 5.1x |
| Sat, 08 Feb 2025 | ₹29.1t | ₹5.2t | ₹663.4b | 36.6x | 43.9x | 5.6x |
| Mon, 06 Jan 2025 | ₹30.2t | ₹5.0t | ₹648.5b | 39.3x | 46.6x | 6x |
| Wed, 04 Dec 2024 | ₹29.2t | ₹5.0t | ₹642.9b | 39.8x | 45.4x | 5.8x |
| Fri, 01 Nov 2024 | ₹28.6t | ₹4.9t | ₹617.0b | 41.4x | 46.3x | 5.8x |
| Sun, 29 Sep 2024 | ₹29.4t | ₹4.9t | ₹605.3b | 42.9x | 48.6x | 6x |
| Tue, 27 Aug 2024 | ₹27.9t | ₹4.9t | ₹605.1b | 39.7x | 46.1x | 5.7x |
| Thu, 25 Jul 2024 | ₹25.8t | ₹4.7t | ₹559.5b | 37.8x | 46x | 5.5x |
| Sat, 22 Jun 2024 | ₹24.0t | ₹4.6t | ₹546.3b | 35.7x | 43.9x | 5.2x |
| Mon, 20 May 2024 | ₹23.4t | ₹4.7t | ₹542.8b | 35.4x | 43.2x | 5x |
| Wed, 17 Apr 2024 | ₹22.7t | ₹4.6t | ₹512.8b | 33.7x | 44.3x | 4.9x |
| Fri, 15 Mar 2024 | ₹22.3t | ₹4.6t | ₹512.5b | 32.6x | 43.4x | 4.8x |
| Sun, 11 Feb 2024 | ₹22.7t | ₹4.5t | ₹518.8b | 38.1x | 43.8x | 5x |
| Tue, 09 Jan 2024 | ₹21.0t | ₹4.4t | ₹476.9b | 37.6x | 44x | 4.8x |
| Thu, 07 Dec 2023 | ₹19.6t | ₹4.4t | ₹476.1b | 33x | 41.2x | 4.4x |
| Sat, 04 Nov 2023 | ₹17.9t | ₹4.3t | ₹461.8b | 32.2x | 38.9x | 4.2x |
| Mon, 02 Oct 2023 | ₹18.3t | ₹4.3t | ₹451.6b | 33x | 40.5x | 4.3x |
| Wed, 30 Aug 2023 | ₹17.8t | ₹4.2t | ₹450.7b | 31.2x | 39.5x | 4.2x |
| Fri, 28 Jul 2023 | ₹17.5t | ₹4.1t | ₹431.1b | 28.9x | 40.7x | 4.3x |
| Sun, 25 Jun 2023 | ₹15.9t | ₹4.1t | ₹425.6b | 28.1x | 37.4x | 3.9x |
| Tue, 23 May 2023 | ₹14.3t | ₹4.0t | ₹394.9b | 28.1x | 36.3x | 3.6x |
| Thu, 20 Apr 2023 | ₹13.9t | ₹3.9t | ₹373.0b | 26.6x | 37.3x | 3.6x |
Price to Earnings Ratio
37.3x
Current Industry PE
- Investors are pessimistic on the Indian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 38.1x which is lower than its 3-year average PE of 41.8x.
- The industry is trading close to its 3-year average PS ratio of 5.1x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 28% per year over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare sector?
| IN Market | 6.90% | |
| Healthcare | 3.42% | |
| Healthtech | 14.54% | |
| Medical Equipment | 7.92% | |
| Life Sciences | 5.59% | |
| Healthcare Services | 4.88% | |
| Pharma | 2.68% | |
| Biotech | -1.02% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 60.9x.
- Analysts are expecting annual earnings growth of 56.8%, which is higher than its past year's earnings growth of 31.5% per year.
- Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 36.5x.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 57% over the next 5 years.
- This is better than its past earnings growth rate of 31% per year.
- In contrast, the Medical Equipment industry is expected to see its earnings grow by 16% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIVISLAB Divi's Laboratories | ₹6.12k | 4.4% +₹69.0b | 9.4% | PE65.5x | |
| 500420 Torrent Pharmaceuticals | ₹4.16k | 4.2% +₹56.9b | 32.9% | PE61.9x | |
| ZYDUSLIFE Zydus Lifesciences | ₹915.40 | 5.9% +₹51.5b | 5.4% | PE18.7x | |
| ANTHEM Anthem Biosciences | ₹744.40 | 12.7% +₹47.0b | n/a | PE86.3x | |
| FORTIS Fortis Healthcare | ₹847.85 | 7.5% +₹44.6b | 30.5% | PE66.7x |
